By recognizing certain antigenic surface proteins such as CEA expressed on circulating tumor cells, these monoclonal-antibody-functionalized micromotors could selectively bind to target circulating tumor cells and then effectively transport them in phosphate-buffered saline and serum. The gene discussed is CEACAM5; the disease is neoplasm.